Display options
Cite
Al-Minshawy SM, El-Mazary AA. An Egyptian child with erythromelalgia responding to a new line of treatment: a case report and review of the literature. J Med Case Rep. 2014;8:69doi: 10.1186/1752-1947-8-69.
Al-Minshawy, S. M., & El-Mazary, A. A. (2014). An Egyptian child with erythromelalgia responding to a new line of treatment: a case report and review of the literature. Journal of medical case reports, 869. https://doi.org/10.1186/1752-1947-8-69
Al-Minshawy, Samir M, and El-Mazary, Abdel-Azeem M. "An Egyptian child with erythromelalgia responding to a new line of treatment: a case report and review of the literature." Journal of medical case reports vol. 8 (2014): 69. doi: https://doi.org/10.1186/1752-1947-8-69
Al-Minshawy SM, El-Mazary AA. An Egyptian child with erythromelalgia responding to a new line of treatment: a case report and review of the literature. J Med Case Rep. 2014 Feb 25;8:69. doi: 10.1186/1752-1947-8-69. PMID: 24568362; PMCID: PMC3943265.
Copy Download .nbib Format: NLM
Share it on

J Med Case Rep. 2014 Feb 25;8:69. doi: 10.1186/1752-1947-8-69.

An Egyptian child with erythromelalgia responding to a new line of treatment: a case report and review of the literature.

Journal of medical case reports

Samir M Al-Minshawy, Abdel-Azeem M El-Mazary

Affiliations

  1. Department of Pediatrics, Minia University, Postcode 61111 Minia city, Egypt. [email protected].

PMID: 24568362 PMCID: PMC3943265 DOI: 10.1186/1752-1947-8-69

Abstract

INTRODUCTION: Erythromelalgia is a rare clinical syndrome characterized by episodic erythema, warmth and intense burning pain, which commonly involves the extremities. For those affected, this disorder may lead to significant long-term morbidity. Unfortunately, to date, no definitive therapy is available. This case report describes an Egyptian child with primary erythromelalgia that manifested at an early age and showed partial response to therapy with cetirizine hydrochloride. This anecdotal case report may have a diagnostic value for clinicians who have not seen this disorder.

CASE PRESENTATION: A 34-month-old previously healthy right-handed Hamitic boy without any significant past medical history presented at the age of 2 years with episodic bilateral pain in his feet. His mother reported associated warmth and erythema localized to his feet that never extended beyond his ankle joints. This pain is triggered by exertion and/or warm temperature exposure and is relieved by cooling measures. The diagnosis of erythromelalgia was made based on the patient's medical history and a thorough physical examination during the episodes. No evidence of local or systemic infection was present. Other causes for the symptoms were excluded by a negative extensive diagnostic work-up. Our patient did not respond to ibuprofen (15mg/kg/dose) three times a day but partial improvement with the oral non-sedating antihistaminic cetirizine hydrochloride (2.5mg/kg/once daily) was observed. When the child stopped cetirizine hydrochloride for 1 month as a test, the symptoms became aggravated and were relieved when cetirizine therapy was restarted. Cetirizine hydrochloride had not previously been reported to have this effect in children with erythromelalgia.

CONCLUSIONS: Erythromelalgia is a clinical syndrome of which the etiology, diagnosis and management are controversial. We describe a case of a 34-month-old Egyptian child with primary erythromelalgia that manifested at an early age. We believe that this is the first Egyptian case report of this kind in the literature. Partial response of this patient to cetirizine hydrochloride may grant us a new clue to understanding this mysterious condition.

References

  1. Pediatrics. 2005 Apr;115(4):e504-7 - PubMed
  2. Brain. 2011 Jul;134(Pt 7):1972-86 - PubMed
  3. J Neurosci. 2004 Sep 22;24(38):8232-6 - PubMed
  4. Ann Neurol. 2009 Jun;65(6):733-41 - PubMed
  5. Ann Dermatol Venereol. 2003 Apr;130(4):429-33 - PubMed
  6. Neurology. 1983 May;33(5):670 - PubMed
  7. Pain. 2012 Jan;153(1):80-85 - PubMed
  8. PLoS One. 2013;8(1):e55212 - PubMed
  9. J Pediatr. 1979 Apr;94(4):619-21 - PubMed
  10. Trends Neurosci. 2007 Nov;30(11):555-63 - PubMed
  11. J Invest Dermatol. 2000 Apr;114(4):643-6 - PubMed
  12. Brain. 2005 Aug;128(Pt 8):1847-54 - PubMed
  13. Ann Pharmacother. 2002 Feb;36(2):255-60 - PubMed
  14. Nat Commun. 2012;3:1186 - PubMed
  15. J Auton Nerv Syst. 1996 Apr 20;58(1-2):121-2 - PubMed
  16. Pain Med. 2006 Nov-Dec;7(6):534-8 - PubMed
  17. Int J Dermatol. 1995 Feb;34(2):97-100 - PubMed
  18. Lancet. 1977 Aug 20;2(8034):412 - PubMed
  19. J Intern Med. 1997 Sep;242(3):191-7 - PubMed
  20. Vasa. 2012 Jan;41(1):43-8 - PubMed
  21. Brain. 2003 Mar;126(Pt 3):567-78 - PubMed
  22. J Clin Invest. 2007 Dec;117(12):3603-9 - PubMed
  23. Ann Neurol. 2006 Mar;59(3):553-8 - PubMed
  24. Vasc Med. 2012 Feb;17(1):44-9 - PubMed
  25. Arch Pediatr. 2013 Apr;20(4):369-71 - PubMed
  26. J Am Acad Dermatol. 2012 Mar;66(3):416-23 - PubMed
  27. J Invest Dermatol. 2002 Apr;118(4):699-703 - PubMed
  28. Ann Saudi Med. 2009 Jul-Aug;29(4):316-8 - PubMed
  29. Arch Dermatol. 2005 Oct;141(10):1320-1 - PubMed
  30. J Neurosci. 2008 Oct 22;28(43):11079-88 - PubMed
  31. Curr Treat Options Cardiovasc Med. 2006 Apr;8(2):153-65 - PubMed
  32. Clin Auton Res. 2013 Apr;23(2):105-7 - PubMed
  33. Arch Dermatol. 2000 Mar;136(3):330-6 - PubMed
  34. Arch Dermatol. 2003 Oct;139(10):1337-43 - PubMed
  35. Nat Rev Neurosci. 2013 Jan;14(1):49-62 - PubMed
  36. J Child Neurol. 2012 Jul;27(7):922-3 - PubMed

Publication Types